Vivimed Labs acquires US FDA approved formulation manufacturing facility

01 Aug 2013 Evaluate

Vivimed Labs has acquired Actavis Pharma Manufacturing’s (APMPL) solid oral dosage facility in Alathur, Tamil Nadu for Rs 122 crore. The facility, which Vivimed acquired from APMPL’s parent Actavis Holding Asia BV, has already received the US Food and Drug Administration (US FDA) approval. 

Along with the facility, the company has also acquired two commercially valuable and marketable Abbreviated New Drug Applications (ANDAs) which will allow the company to generate additional revenues.

Vivimed Labs’s manufacturing unit is located at Bidar, Karnataka, where it was originally engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and bulk drugs like Ibuprofen etc.

Vivimed Labs Share Price

5.75 0.00 (0.00%)
31-Jul-2023 18:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.45
Dr. Reddys Lab 1275.50
Cipla 1511.40
Zydus Lifesciences 925.70
Lupin 2082.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×